Clinical trial
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
NCT00174382 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00174382 |
|---|---|
| Title | Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia |
| Official title | An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dementia, Vascular, Mixed |
| Intervention type | Drug |
| Interventions | Donepezil |
| Enrollment | 149 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 24, 2015 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: